Stopping Levothyroxine in Subclinical Hypothyroidism Safe, Feasible

Despite apparent lack of benefits, many still receive levothyroxine for subclinical hypothyroidism. Study helps fill a data gap on discontinuation.
Medscape Medical News

source https://www.medscape.com/viewarticle/982905?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?